Literature DB >> 7263315

HLA antigens and immunoglobulin allotypes in patients with malignant melanoma.

J P Pandey, A H Johnson, H H Fudenberg, D B Amos, J U Gutterman, E M Hersh.   

Abstract

HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263315     DOI: 10.1016/0198-8859(81)90010-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  IgG heavy-chain (Gm) allotypes in familial polyposis coli.

Authors:  J P Pandey; P Ebbesen; S Bülow; L B Svendsen; H H Fudenberg
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

2.  A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1).

Authors:  S Whittingham; D N Propert; I R Mackay
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.

Authors:  J P Pandey; A M Namboodiri; Y Ohue; M Oka; E Nakayama
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

4.  Heterozygosity at Gm loci associated with humoral immunity to osteosarcoma.

Authors:  J P Pandey; B T Shannon; K Y Tsang; H H Fudenberg; J G Camblin
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

5.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.